Patent details

EP3883606 Title: SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL12/IL23 ANTIBODY

Basic Information

Publication number:
EP3883606
PCT Application Number:
IB2019058098
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP198670853
PCT Publication Number:
WO2020065532
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL12/IL23 ANTIBODY
French Title of Invention:
MÉTHODE SÛRE ET EFFICACE DE TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AVEC UN ANTICORPS ANTI-IL12/IL23
German Title of Invention:
SICHERE UND WIRKSAME METHODE ZUR BEHANDLUNG VON COLITIS ULCEROSA MIT ANTI-IL12/IL23-ANTIKÖRPER
SPC Number:

Dates

Filing date:
24/09/2019
Grant date:
12/07/2023
EP Publication Date:
29/09/2021
PCT Publication Date:
02/04/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
12/07/2023
EP B1 Publication Date:
12/07/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/09/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/07/2023
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
20/07/2023
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
STRAUSS, Richard
Address:
United States (US)

2

Name:
MARANO, Colleen
Address:
United States (US)

3

Name:
O'BRIEN, Christopher
Address:
United States (US)

4

Name:
SHIELDS-TUTTLE, Kimberly
Address:
United States (US)

5

Name:
ADEDOKUN, Omoniyi
Address:
United States (US)

6

Name:
JOHANNS, Jewel
Address:
United States (US)

7

Name:
LI, Katherine
Address:
United States (US)

8

Name:
ZHANG, Hongyan
Address:
United States (US)

Priority

1

Priority Number:
201862735501 P
Priority Date:
24/09/2018
Priority Country:
United States (US)

2

Priority Number:
201862769818 P
Priority Date:
20/11/2018
Priority Country:
United States (US)

3

Priority Number:
201962895774 P
Priority Date:
04/09/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; C07K 14/54;

Publication

European Patent Bulletin

1

Issue number:
202328
Publication date:
12/07/2023
Description:
Grant (B1)

2

Issue number:
202420
Publication date:
15/05/2024
Description:
Opposition procedure started

3

Issue number:
202335
Publication date:
30/08/2023
Description:
Opposition procedure started

4

Issue number:
202411
Publication date:
13/03/2024
Description:
Opposition procedure started

5

Issue number:
202611
Publication date:
11/03/2026
Description:
Termination of the opposition

6

Issue number:
202447
Publication date:
20/11/2024
Description:
Document reprinted after correction (B8, B9)

7

Issue number:
202340
Publication date:
04/10/2023
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/09/2025
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
20/07/2023 Power Of Attorney 1
20/07/2023 Outgoing Correspondence 1